What is Rapport Therapeutics, Inc.'s net investment in lease?

Rapport Therapeutics, Inc. (RAPP) reported net investment in lease of $9.33M in Q1 2026.

How has Rapport Therapeutics, Inc.'s net investment in lease changed year-over-year?

Rapport Therapeutics, Inc.'s net investment in lease increased by 24.9% year-over-year, from $7.47M to $9.33M.

What is the long-term trend for Rapport Therapeutics, Inc.'s net investment in lease?

Over 2 years (2023 to 2025), Rapport Therapeutics, Inc.'s net investment in lease has grown at a 118.1% compound annual growth rate (CAGR), from $2.08M to $9.91M.

Rapport Therapeutics, Inc. RAPP Net Investment in Lease

Net Investment in Lease at other companies

Supernus PharmaceuticalsSUPN

——

Xenon PharmaceuticalsXENE

——

Praxis Precision Medicines, Inc.PRAX

——

BiohavenBHVN

——

Septerna, Inc.SEPN

——

PVL

Palvella TherapeuticsPVLA

——

Other financials

Income statement

See full

Revenue$20.0M—

Operating income-$24.2M+10.7%

Net income-$19.9M+17.5%

EPS (diluted)-$0.42+38.2%

Balance sheet

See full

Cash & equivalents$78.1M+35.5%

Total debt$10.8M+37.8%

Total equity$471.5M+65.0%

Total assets$497.6M+64.7%

Cash flow

See full

Operating cash flow-$13.1M+35.5%

CapEx$86.0K-70.4%

Free cash flow-$13.1M+36.0%

Valuation

See full

Market cap$1.91B+309%

Returns & leverage

See full

Return on equity-28.3%—

Debt / equity0×0.0×

Current ratio27.1×-3.9×

Where this comes from

Reported directly by Rapport Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Rapport Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rapport Therapeutics, Inc.'s net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Rapport Therapeutics, Inc.'s net investment in lease?: Rapport Therapeutics, Inc. (RAPP) reported net investment in lease of $9.33M in Q1 2026.
How has Rapport Therapeutics, Inc.'s net investment in lease changed year-over-year?: Rapport Therapeutics, Inc.'s net investment in lease increased by 24.9% year-over-year, from $7.47M to $9.33M.
What is the long-term trend for Rapport Therapeutics, Inc.'s net investment in lease?: Over 2 years (2023 to 2025), Rapport Therapeutics, Inc.'s net investment in lease has grown at a 118.1% compound annual growth rate (CAGR), from $2.08M to $9.91M.